Cue Biopharma, Inc.
CUE
$0.56
-$0.01-1.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.45M | -8.48M | -12.26M | -9.50M | -8.66M |
| Total Depreciation and Amortization | -1.40M | 1.58M | 101.00K | 2.05M | -1.41M |
| Total Amortization of Deferred Charges | 10.00K | 9.00K | 9.00K | 9.00K | 10.00K |
| Total Other Non-Cash Items | 3.43M | 515.00K | 2.15M | -691.00K | 3.81M |
| Change in Net Operating Assets | -3.62M | 2.97M | 1.82M | -901.00K | -1.27M |
| Cash from Operations | -9.02M | -3.42M | -8.17M | -9.03M | -7.53M |
| Capital Expenditure | 0.00 | -27.00K | -150.00K | -2.00K | 1.00K |
| Sale of Property, Plant, and Equipment | 20.00K | -- | -- | 1.00K | 97.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.79M | -- | -- | -- | -- |
| Cash from Investing | -6.77M | -27.00K | -150.00K | -1.00K | 98.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00M | -1.00M | -1.00M | -999.00K | -1.00M |
| Issuance of Common Stock | 1.00M | 18.80M | -- | 67.00K | 10.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00K | 17.80M | -1.00M | -932.00K | 9.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.79M | 14.36M | -9.32M | -9.96M | 2.39M |